Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:513881991:1778 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:513881991:1778?format=raw |
LEADER: 01778cam a2200409 a 4500
001 3957722
005 20221027005858.0
008 910626s1991 enka b 001 0 eng c
010 $a 90013134
020 $a0471928909
035 $a(OCoLC)501419012
035 $a(OCoLC)ocn501419012
035 $a(CStRLIN)NYCM91-B2905
035 $9AFL1195HS
035 $a(NNC)3957722
035 $a3957722
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRM332$b.F45 1991
060 0 $aQV 126 F297s
082 00 $a616.85/27061$220
100 1 $aFeighner, John Preston,$d1937-$0http://id.loc.gov/authorities/names/n83066342
245 10 $aSelective serotonin re-uptake inhibitors /$cJ.P. Feighner and W.F. Boyer.
260 $aChichester ;$aNew York :$bWiley,$c1991.
300 $a168 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aPerspectives in psychiatry ;$vv. 1
504 $aIncludes bibliographical references and index.
650 0 $aAntidepressants.$0http://id.loc.gov/authorities/subjects/sh85005661
650 0 $aSerotonin$xAgonists.$0http://id.loc.gov/authorities/subjects/sh96010269
650 0 $aSerotoninergic mechanisms.$0http://id.loc.gov/authorities/subjects/sh89006313
650 2 $aDepression$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D003863Q000188
650 2 $aDepressive Disorder$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D003866Q000188
650 2 $aSerotonin Antagonists$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D012702Q000627
700 1 $aBoyer, W. F.$0http://id.loc.gov/authorities/names/n89230126
830 0 $aPerspectives in psychiatry (Chichester, England) ;$vv. 1.$0http://id.loc.gov/authorities/names/n88525781
852 00 $boff,hsl$hRM332$i.F45 1991